Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil and Attention on Visual Spatial Representations
NCT05003063Phase 1Completed
- Sponsor
- University of California, Berkeley
- Start
- Feb 2021
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Alzheimer's disease (AD) comparing Donepezil with Placebo (2 arms). Primary endpoint: Population receptive field size. Started Feb 2021; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT05003063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05003063.